Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,210 total articles
LifeVantage Corporation announced that its Board of Directors granted inducement awards to its new President and CEO, Terrence Moorehead, under its 2026 New Employee Long-Term Incentive Plan, including restricted stock units and performance-based restricted stock units vesting over three years based on revenue and profitability targets.
Aardvark Therapeutics announced the termination of its Phase 3 HERO and OLE trials for ARD-101 in Prader-Willi Syndrome following a full clinical hold imposed by the FDA. The company is currently assessing unblinded trial data to decide on next steps. It reported a net loss of $14.4 million for Q2 2026 with a cash runway expected into late 2027.
NOVAGOLD RESOURCES INC. and Donlin Gold Holdings LLC (owned by Paulson Advisers) have appointed Endeavour Financial and Macquarie Capital as financial advisors to support financing strategies for the Donlin Gold project in Alaska. The advisors will assist in evaluating funding alternatives, including project and infrastructure finance, to position …
Apollomics Inc., a clinical-stage biopharmaceutical company focused on oncology therapies, announced a $10 million private placement. The financing includes cash investments and conversion of convertible notes from insiders and accredited investors, supporting ongoing clinical trials of its lead drug candidate, vebreltinib, for treating non-small c…
Stran & Company, Inc. (NASDAQ: SWAG) announced its financial results for Q2 and the first half of 2026, reporting revenue growth, improved gross profit, and doubled EBITDA compared to the prior year. The Company expanded its enterprise footprint with significant new contracts and continued to improve profitability in its loyalty solutions segment. …
FocalTherics announced preliminary unaudited Q2 2026 financial results, showing significant revenue and gross margin growth in its continuing HIFU segment. The company is exiting its ESWL and Distribution segments, marking a strategic shift to focus on robotic focal therapy technology. Cash and equivalents totaled $21.5 million as of June 30, 2026,…
Vornado Realty Trust is partnering with Rudin Management and an affiliate of Kenneth Griffin, founder and CEO of Citadel, to develop a 1.9 million square foot trophy office building at 350 Park Avenue in New York City. Citadel Enterprise Americas will anchor the building with a 15-year lease for 1.05 million square feet. The $6.2 billion project in…
FocalTherics, a global leader in robotic energy-based therapies, has initiated a proposed underwritten public offering of American Depositary Shares (ADSs) on NASDAQ. The company plans to use the net proceeds to cover operating costs, capital expenditures, and general corporate purposes. The offering is subject to market conditions and includes an …
Artisan Partners Asset Management Inc. announced that its preliminary assets under management as of July 31, 2026 totaled $183.0 billion, with $94.3 billion in Artisan Funds and Artisan Global Funds and $88.7 billion in separate accounts and other AUM. The breakdown of AUM by strategy was detailed, with various investment teams managing different a…
Fabrinet, a global provider of advanced optical packaging and precision manufacturing services, announced that its management team will present at the Rosenblatt 6th Annual Age of AI Technology Summit on August 18, 2026. The presentation will be available via live webcast and replay on the company's investor website.
Fold Holdings, Inc., the first publicly traded bitcoin financial services company, announced second quarter 2026 results reporting $6.1 million in revenue and a net loss of $9.7 million. The company eliminated $20 million of secured debt and expanded its Fold Credit Card program to over 2,000 cardholders in early access, doubling from the previous …
DoubleDown Interactive announced strong Q2 2026 financial results, with revenue rising 11.2% year-over-year to $94.3 million and earnings per fully diluted common share increasing 50.5% to $13.27. Growth was driven by the acquisition of WHOW Games GmbH and notable expansion in its Direct-to-Consumer segment, which now accounts for over 50% of total…
Arbor Realty Trust announced the closing of an $825 million commercial real estate mortgage loan securitization, issuing $730.1 million of investment grade notes and retaining $112.4 million in subordinate interests. Proceeds will be used to repay credit facility borrowings, cover transaction costs, and finance future loan originations. The securit…
Tandy Leather Factory announced its financial results for the second quarter of 2026, showing a 1.5% increase in revenue to $18.0 million and a significant rise in operating income by 722.9% year-over-year. The company improved gross margins to 64.8% and reported net income of $0.4 million compared to a net loss the previous year. Despite a reducti…
Reed's, Inc. reported its second quarter 2026 financial results with net sales decreasing to $7.5 million from $9.5 million a year ago, driven by lower volumes from national customers. However, the company demonstrated operational improvements with gross profit increasing to $1.8 million and gross margin rising to 24% from 8%. Operating expenses an…
Firefly Aerospace announced its second-quarter 2026 financial results with record revenue of $117.7 million, a 659% year-over-year increase. The company secured over six contracts in Q2, including a $144 million NASA Commercial Lunar Payload Services contract for a rapid Moon lander mission and a $75 million subcontract supporting NASA's MoonFall m…
Cardiff Oncology announced positive Phase 2 clinical trial results for onvansertib combined with FOLFIRI/bevacizumab in first-line RAS-mutated metastatic colorectal cancer at ASCO 2026. Following a successful End-of-Phase 2 meeting with the FDA, the company plans to initiate a Phase 3 registrational trial in early 2027, contingent on securing addit…
Sanara MedTech Inc. reported a 9% increase in net revenue to $28.1 million for Q2 2026 compared to Q2 2025, with strong gross margins of 93%. The company announced an expected acquisition by MiMedx, aiming to create a leading regenerative medicine company. Despite a slight net loss due to increased SG&A and interest expenses, Adjusted EBITDA improv…
SINTX Technologies provided a mid-year 2026 business update highlighting progress in commercializing its FDA-cleared SiNAPTIC Foot & Ankle Implant System, expansion of its distribution network, additional capital raises, and growth in its industrial ceramics segment. The company is moving from technology development to commercial execution, investi…
Canterbury Park Holding Corporation reported a 3.2% increase in net revenues to $16.2 million for Q2 2026 and a 29.3% increase in adjusted EBITDA to $2.6 million, reflecting growth across Casino, Pari-mutuel, and Food and Beverage operations. Despite a net loss due to an impairment charge linked to prior horserace purse overpayments, the company sh…
Black Rock Coffee Bar, Inc. announced strong second quarter 2026 results, featuring a 25.0% year-over-year increase in total revenue to $63.0 million and a 4.2% same store sales growth. The company opened 10 new stores during the quarter, expanding its footprint to 200 locations systemwide. Income from operations grew to $4.1 million, and net incom…
Inuvo, Inc. announced the retirement of its long-serving CFO Wallace Ruiz after 16 years, with Derric Ciccone appointed as President and CFO and Aleesha Parris promoted to Chief Accounting Officer. The leadership changes aim to support Inuvo's continued scaling and transformation in AI-driven advertising technology.
Snail, Inc. announced its Q2 2026 financial results showing a slight decrease in net revenues but a significant improvement in net loss. The company expanded its ARK franchise with new DLCs, saw positive early engagement with the Bellwright console launch, and showcased progress on several upcoming AAA games. Additionally, Snail introduced an AI ga…
LENZ Therapeutics reported $5.5 million revenue in Q2 2026 driven by VIZZ (aceclidine ophthalmic solution) sales and global licensing agreements. Strong patient refill rates and the launch of a telehealth prescribing channel in July 2026 are early indicators of sustained growth. The company expanded international partnerships and regulatory submiss…
Bolt Biotherapeutics announced its second quarter 2026 financial results and provided an update on its lead candidate BDC-4182, a Boltbody ISAC targeting claudin 18.2 for gastric and gastroesophageal cancers. The Phase 1/2 clinical trial is ongoing with patients in Cohort 4 and initial clinical data are expected in Q3 2026. The company had $18.1 mi…
